Impact of Galcanezumab on Total Pain Burden: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Episodic Cluster Headache

por Andrews, J Scott, Kudrow, David, Rettiganti, Mallikarjuna, Oakes, Tina, Bardos, Jennifer N, Wenzel, Richard, Kuruppu, Dulanji K, Gaul, Charly, Martinez, James M
Publicado 2021

Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review

por Dodick, David W., Goadsby, Peter J., Ashina, Messoud, Tassorelli, Cristina, Hundemer, Hans‐Peter, Bardos, Jennifer N., Wenzel MD, Richard, Kemmer, Phebe, Conley, Robert, Martinez, James M., Oakes, Tina
Publicado 2022

Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment

por Dodick, David W, Goadsby, Peter J, Lucas, Christian, Jensen, Rigmor, Bardos, Jennifer N, Martinez, James M, Zhou, Chunmei, Aurora, Sheena K, Yang, Jyun Yan, Conley, Robert R, Oakes, Tina
Publicado 2020